However, hepatic hepcidin mRNA showed an opposite direction of change: contrary to a decrease after blood loss (0.32±0.1 fold of control, p<0.005), liver hepcidin mRNA increased in the CKD group (1.8±0.1 fold of C, p< 0.0001). This evidence concerns the gene HAMP and chronic kidney disease.